Literature DB >> 2355239

Haemodilution and oxygen transport capacity.

A Haass, F Jung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2355239     DOI： 10.1007/bf00314680

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Autoregulatory capacity and the effect of isovolemic hemodilution on local cerebral blood flow.

Authors:  R von Kummer; J Scharf; T Back; H Reich; H G Machens; B Wildemann
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

2.  [Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks].

Authors:  A Haass; H Kroemer; H Jäger; K Müller; I Decker; E M Wagner; K Schimrigk
Journal:  Dtsch Med Wochenschr       Date:  1986-10-31       Impact factor: 0.628

3.  Microcirculatory effects of normovolemic hemodilution in skeletal muscle.

Authors:  S Mirhashemi; K Messmer; K E Arfors; M Intaglietta
Journal:  Int J Microcirc Clin Exp       Date:  1987-12

4.  Haemodilution with dextran 40 and hydroxyethyl starch and its effect on cerebral microcirculation.

Authors:  J Scharf; R von Kummer; T Back; H Reich; G Machens; B Wildemann
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

5.  Cerebral cortical oxygenation and perfusion during Hetastarch hemodilution.

Authors:  T Shinozuka; E M Nemoto; A L Bleyaert
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

6.  In vivo measurement of regional cerebral haematocrit using positron emission tomography.

Authors:  A A Lammertsma; D J Brooks; R P Beaney; D R Turton; M J Kensett; J D Heather; J Marshall; T Jones
Journal:  J Cereb Blood Flow Metab       Date:  1984-09       Impact factor: 6.200

7.  Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroxyethyl starch 200/0.5.

Authors:  H Kroemer; A Haass; K Müller; H Jäger; E M Wagner; P Heimburg; U Klotz
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.